PARIS, December 02, 2025--(BUSINESS WIRE)--Trustech, the leading international event for trust-based technologies and the flagship exhibition for the identity and payments sectors, provides the ...
COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector development and ...
Parks will spearhead development and execution of Matica Bio’s commercial strategic initiatives as EVP of Commercial Operations Sugrue to advance business development goals, partnerships as VP of ...
A lack of global capacity to produce cell and gene therapies has been exacerbated by an even more pressing need: to develop and manufacture coronavirus vaccines. So it appears the timing is right for ...
COLLEGE STATION, Texas and SAN DIEGO, June 16, 2026 /PRNewswire/ -- **Matica Biotechnology, Inc. (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in ...
CHA Biotech said on the 3rd that its U.S. subsidiary Matica Biotechnology signed a CDMO (contract development and manufacturing) deal with Kalidi Biotherapeutics. Kalidi develops oncolytic virus ...
Matica Biotechnology, local firm Cha Biotech’s US subsidiary, has set out a goal of posting 1 trillion won ($761 million) in annual sales to become a global top five contract development and ...
Kim to oversee cell and gene therapy (CGT) manufacturing operations, processes, operations, and business strategy as CEO during period of rapid expansion across US and Korea COLLEGE STATION, ...
COLLEGE STATION, Texas, July 6, 2026 /PRNewswire/ -- Matica Biotechnology, Inc. ("Matica Bio"), a viral vector contract development and manufacturing organization (CDMO), is partnering with ...
New platform positions Korea as a strategic alternative for investigator initiated trials (IIT) and early translational studies in cell and gene therapy Developed in collaboration with Korea's top ...
Matica Biotechnology, a U.S. affiliate of Korea’s CHA Biotech, said Tuesday that it has signed a contract development and manufacturing deal with Cirsium Biosciences, a U.S. biotech firm developing ...
Matica Enterprises Inc, a Toronto-based cannabis company, has secured a draw-down equity facility of up to $20 million from Alumina Partners, a U.S. private equity firm. The facility’s proceeds will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results